We clearly demonstrated statistically significant ligand-driven up-regulation of GLI1 mRNA expression and statistically significant vismodegib-driven down-regulation of GLI1 mRNA expression by 3 clinically relevant doses of vismodegib in a dose dependent manner in GBM neurospheres in vitro. This evidence concerns the gene GLI1 and glioblastoma.